Viralytics Ltd (OTCQX International:VRACY.PK)

Data as of Sep 30
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Viralytics Ltd. is a biotechnology company. The company focuses on the development of oncolytic virotherapy for the treatment of cancers. Its products include CAVATAKô and EVATAKô. The company was founded on August 14, 1986 and is headquartered in Sydney, Australia.

Contact Information

Viralytics Ltd.
66 Hunter Street
Sydney New South Wales (nsw) 2000
P:(129) 988-4000
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Malcolm L. McCollChief Executive Officer
Robert C. VickeryChief Financial Officer
Darren ShafrenChief Scientific Officer
Catherine OfficerSecretary

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.